Although predominately mediated by VEGF-C and -D interaction with VEGFR3, recent data demonstrated elevated expression of tumor-derived VEGF-A contributes to pathological lymphangiogenesis [47]–[48]. This evidence concerns the gene FLT4 and neoplasm.